BRAINP
CO

Brain+ ApS

Overview
BRAINP
Symbol
CO
Exchange
About stock

Brain+ A/S develops Digital Therapeutics, a prescription treatment for Alzheimer's and dementia. It offers Recover, a gamified cognitive training application. The company also develops cognitive stimulation therapy (CST), a dialogue-based therapy for Alzheimer's; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, an app-based memory test to detect early cognitive decline related to Alzheimer's.

In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was founded in 2012 and is based in Copenhagen, Denmark. Address: Købmagergade 53, Copenhagen, Denmark, 1150

Brain+ ApS dividend calculator
Report issue